Hyponatremia: Difference between revisions
| Line 136: | Line 136: | ||
==Treatment== | ==Treatment== | ||
Hyponatremia is due to an excess of free water in the body, not due to a deficiency of sodium. The treatment of hyponatremia is therefore free water restriction. In patients who are receiving intravenous therapy, you should make sure that D<sub>5</sub>W is not infusing, and that drug infusions are mixed in normal saline, and not D<sub>5</sub>W. The patients access to water and juice should be restricted. In some refractory cases, the water to the room must be turned off. | Hyponatremia is due to an excess of free water in the body, not due to a deficiency of sodium. The treatment of hyponatremia is therefore free water restriction. In patients who are receiving intravenous therapy, you should make sure that D<sub>5</sub>W is not infusing, and that drug infusions are mixed in normal saline, and not D<sub>5</sub>W. The patients access to water and juice should be restricted. In some refractory cases, the water to the room must be turned off. | ||
===Rate of Na Correction=== | |||
The rate of correction of [[hyponatremia]] should be 0.5-1.0meq/L/hr, with not more than a 12 meq/l correction in 24 hrs. If the patient has ongoing [[seizures]] (or [Na<sup>+</sup>]<115 meq/li), correction can be attempted at up to 2 meq/L/hr, but only while [[seizure activity]] lasts and the [Na<sup>+</sup>] exceeds 125-130 meq/Li. | |||
== See also == | == See also == | ||
Revision as of 21:24, 11 August 2012
Template:DiseaseDisorder infobox
|
WikiDoc Resources for Hyponatremia |
|
Articles |
|---|
|
Most recent articles on Hyponatremia Most cited articles on Hyponatremia |
|
Media |
|
Powerpoint slides on Hyponatremia |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Hyponatremia at Clinical Trials.gov Clinical Trials on Hyponatremia at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Hyponatremia
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Hyponatremia Discussion groups on Hyponatremia Patient Handouts on Hyponatremia Directions to Hospitals Treating Hyponatremia Risk calculators and risk factors for Hyponatremia
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Hyponatremia |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The electrolyte disturbance hyponatremia (British hyponatraemia) exists in humans when the sodium (Natrium in Latin) concentration in the plasma falls below 130 mmol/L. At lower levels water intoxication may result, an urgently dangerous condition. Hyponatremia is an abnormality that can occur in isolation or, as most often is the case, as a complication of other medical illnesses.
Causes
An abnormally low plasma sodium level is best considered in conjunction with the person's plasma osmolarity and extracellular fluid volume status.
Most cases of hyponatremia are associated with reduced plasma osmolarity. In fact, the vast majority of adult cases are due to increased vasopressin, i.e., anti-diuretic hormone (ADH). Vasopressin is a hormone that causes retention of water, but not salt. Hence, the patient with hyponatremia can be viewed as the patient with increased ADH activity. It is the physician's task to identify the cause of the increased ADH activity in each case.
In patients who are volume depleted, i.e., their blood volume is too low, ADH secretion is increased, since volume depletion is a potent stimulus for ADH secretion. As a result, the kidneys of such patients hold on to water and produce a very concentrated urine. Treatment is simple (if not without risk) — simply restore the patient's blood volume, thereby turning off the stimulus for ongoing ADH release and water retention.
Some patients with hyponatremia have normal blood volume. In those patients, the increased ADH activity and subsequent water retention may be due to "physiologic" causes of ADH release such as pain or nausea. Alternatively, they may have the Syndrome of Inappropriate ADH (SIADH). SIADH represents the sustained, non-physiologic release of ADH and most often occurs as a side effect of certain medicines, lung problems such as pneumonia or abscess, brain disease, or certain cancers (most often small cell lung carcinoma).
A third group of patients with hyponatremia are often said to be "hypervolemic". They are identified by the presence of peripheral edema. In fact, the term "hypervolemic" is misleading since their blood volume is actually low. The edema underscores the fact that fluid has left the circulation, i.e., the edema represents fluid that has exited the circulation and settled in dependent areas. Since such patients do, in fact, have reduced blood volume, and since reduced blood volume is a potent stimulus for ADH release, it is easy to see why they have retained water and become hyponatremic. Treatment of these patients involves treating the underlying disease that caused the fluid to leak out of the circulation in the first place. In many cases, this is easier said than done when one recognizes that the responsible underlying conditions are diseases such as liver cirrhosis or heart failure — conditions that are notoriously difficult to manage, let alone cure.
Hyponatremia can result from dysfunctions of the mineralocorticoid aldosterone (i.e. hypoaldosteronism) due to adrenal insufficiency, congenital adrenal hyperplasia, and some medications.
It is worth considering separately, the hyponatremia that occurs in the setting of diuretic use. Patients taking diuretic medications such as furosemide (Lasix), hydrochlorothiazide, chlorthalidone, etc., become volume depleted. That is to say that their diuretic medicine, by design, has caused their kidneys to produce more urine than they would otherwise make. This extra urine represents blood volume that is no longer there, that has been lost from the body. As a result, their blood volume is reduced. As mentioned above, lack of adequate blood volume is a potent stimulus for ADH secretion and thence water retention.
A recent surge in death from hyponatremia has been attributed to overintake of water while under the influence of MDMA. Also, Almond et al.[1] found hyponatremia in as many as 13% of runners in a recent Boston Marathon, with life-threatening hyponatremia (serum Na below 120 mmol/L) in 0.6%. The runners at greatest risk of serious water intoxication had moderate weight gain during the race due to excessive water consumption (see reference). Siegel et al [2] recently found that in addition to over-zealous drinking, the cause of exercise-associated hyponatremia (EAH) is from an inappropriate secretion of the hormone arginine vasopressin, or antidiuretic hormone. This excess hormone secretion prevents the kidneys from excreting the excess water in the urine.
Causes of Hyponatremia in Alphabetical Order
- Acute or chronic kidney disease
- Addison's Disease
- After pituitary surgery
- After surgery
- Ascites puncture
- Beer Potomania
- Burns
- Cirrhosis
- Congestive Heart Failure (CHF)
- Diabetic coma
- Diabetes with glucosuria
- Diarrhea
- Diuretics
- Drugs
- Excessive hydration
- Fistula
- Gastric drainage
- Glucocorticoid deficiency
- Heart failure
- Hyperglycemia without dehydration
- Hyperlipidemia
- Hyperproteinemia
- Hypoalbuminemia
- Hypothyroidism
- Hypotonic infusions
- Iatrogenic hypotonic infusions
- Ileus
- Ketonuria
- Metabolic acidosis
- Mineralacorticoid deficiency
- Nephrotic syndrome
- Nonsteriodal anti-inflammatory drugs (NSAIDs)
- Pancreatitis
- Patients with urea diuresis
- Peritonitis
- Pleuracentesis
- Pregnancy
- Pseudohyponatremia
- Psychogenic polydipsia
- Psychosis
- Renal Failure
- Renal losses
- Renal Tubular Acidosis
- Subarachnoid hemorrhage
- Syndrome of inappropriate antidiuretic hormone (SIADH)
- Tubulointerstitial kidney disease
- Vomiting
Pseudohyponatremia
Certain conditions that interfere with laboratory tests of serum sodium concentration (such as extraordinarily high blood levels of lipid or protein) may lead to an erroneously low measurement of sodium. This is called pseudohyponatremia, and can occur when laboratories use the flame-photometric and indirect (but not direct) ion-selective electrode assays.[3][4] This is distinct from a true dilutional hyponatremia that can be caused by an osmotic shift of water from cells to the bloodstream after large infusions on mannitol or intravenous immunoglobulin.
Hypoosmolar hyponatremia
When the plasma osmolarity is low, the extracellular fluid volume status may be in one of three states:
- Low volume. Loss of water is accompanied by loss of sodium.
- Excessive sweating
- Burns
- Vomiting
- Diarrhea
- Urinary loss
- Diuretic drugs (especially thiazides)
- Addison's disease
- Cerebral salt-wasting syndrome
- Other salt-wasting kidney diseases
Treat underlying cause and give IV isotonic saline. It is important to note that sudden restoration of blood volume to normal will turn off the stimulus for continued ADH secretion. Hence, a prompt water diuresis will occur. This can cause a sudden and dramatic increase the serum sodium concentration and place the patient at risk for so-called "central pontine myelinolysis" (CPM). That disorder is characterized by major neurologic damage, often of a permanent nature.
Because of the risk of CPM, patients with low volume hyponatremia may eventually require water infusion as well as volume replacement. Doing so lessens the chance of a too rapid increase of the serum sodium level as blood volume rises and ADH levels fall.
- Normal volume.
- SIADH (syndrome of inappropriate antidiuretic hormone)
- Some cases of psychogenic polydipsia
The cornerstone of therapy for SIADH is reduction of water intake. If hyponatremia persists, then demeclocycline (an antibiotic with the side effect of inhibiting ADH) can be used. SIADH can also be treated with specific antagonists of the ADH receptors, such as conivaptan or tolvaptan.
- High volume. There is retention of water.
Placing the patient on water restriction can also help in these cases.
Severe hyponatremia may result from a few hours of heavy exercise in high temperature conditions, such as hiking in desert areas, or from endurance athletic events when electrolytes are not supplied. (Such an incident notably happened to long-distance athlete Craig Barrett in 1998).
Diagnosis
Symptoms
Most patients with chronic water intoxication are asymptomatic, but may have symptoms related to the underlying cause.
Severe hyponatremia may cause osmotic shift of water from the plasma into the brain cells. Typical symptoms include nausea, vomiting, headache and malaise. As the hyponatremia worsens, confusion, diminished reflexes, convulsions, stupor or coma may occur. Since nausea is, itself, a stimulus for the release of ADH, which promotes the retention of water, a positive feedback loop may be created and the potential for a vicious circle of hyponatremia and its symptoms exists.
Laboratory Findings
- Serum osmolality
- Blood urea nitrogen (BUN)/creatinine
- Calcium
- Magnesium
- Urine sodium
- Thyroid stimulating hormone (TSH)
- Serum glucose
Treatment
Hyponatremia is due to an excess of free water in the body, not due to a deficiency of sodium. The treatment of hyponatremia is therefore free water restriction. In patients who are receiving intravenous therapy, you should make sure that D5W is not infusing, and that drug infusions are mixed in normal saline, and not D5W. The patients access to water and juice should be restricted. In some refractory cases, the water to the room must be turned off.
Rate of Na Correction
The rate of correction of hyponatremia should be 0.5-1.0meq/L/hr, with not more than a 12 meq/l correction in 24 hrs. If the patient has ongoing seizures (or [Na+]<115 meq/li), correction can be attempted at up to 2 meq/L/hr, but only while seizure activity lasts and the [Na+] exceeds 125-130 meq/Li.
See also
References
- ↑ Almond CS et al. (2005) Hyponatremia among runners in the Boston Marathon. N Engl J Med, 352(15):1550-6. PMID 15829535
- ↑ Siegel AJ et al. (2007) Am J Med, 120(5):461.e11-7. PMID 17466660
- ↑ Weisberg LS. (1989) Pseudohyponatremia: a reappraisal. Am J Med, 86(3):315-8. PMID 2645773
- ↑ Nguyen MK et al. (2007) A new method for determining plasma water content: application in pseudohyponatremia. Am J Phys - Renal, 292(5):F1652-6. PMID 17299138
Template:Endocrine, nutritional and metabolic pathology